ACT Brief: Community Trial Cost Barriers, Measuring What Matters, and Prostate Cancer Approval

0:00-1:52

In today’s ACT Brief, we examine how cost barriers and site infrastructure limit participation in community trials, why endpoints should reflect what patients actually experience, and how the FDA expanded a prostate cancer combination to an earlier treatment setting.

Publisher

Applied Clinical Trials

Link

audioboom.com/posts/8969492

Published

October 27, 2026

Duration

2 min

Format

Podcast

Category

Issues · Science

Source

RSS feed

AC

Applied Clinical Trials

@appliedclinicaltrials

#actbrief #communitytrialcost #prostatecancerapproval #lifesciences

The Nile